Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Recognitions

Top Cited Scholar (2026)

Ehimario Uche Igumbor has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Insights from strengthening perinatal hepatitis b prevention in healthcare facilities in Delta State, Nigeria: A prospective, pilot implementation intervention

    by Prince Ochuko Okinedo, Catherine Freeland, Ehimario U. Igumbor, Samuel Okwuchukwu Ilikannu, Funso Joshua Eniojukan, Ngozi Roy Maduka, Gregsonil Ogheneruemu Idibofu, Linda Peter-Enyi, Kevin Igweh, Dafe Akokotu, et al.

    Background: Hepatitis B virus (HBV) infection is a leading cause of chronic liver disease and cancer globally, with perinatal transmission representing the predominant route of new infections in high-burden countries such as Nigeria. Despite significant prevalence, screening, diagnosis, and timely intervention for HBV among pregnant women remain suboptimal in Nigeria, contributing to ongoing morbidity and mortality. Objectives: This analysis assessed the impact of interventions to reduce perinatal HBV transmission in five pilot health facilities in Delta State, Nigeria. It evaluated HBV and HCV prevalence among pregnant women, timing of antenatal care (ANC) booking, linkage to care for HBV-positive women, and HepB birth dose (HepB-BD) vaccination coverage and timeliness. Design: The project design was a prospective implementation research which involved a cohort of pregnant women registered for ANC in the five pilot healthcare facilities strategically located across the three senatorial districts of Delta State, Nigeria. These facilities were all high-volume public facilities located and were carefully chosen to ensure representation across different regions of Delta State, providing a diverse perspective on the project’s implementation and impact. The selected facilities provide secondary and tertiary care services. Methods: All pregnant women at five health facilities were screened at their first ANC visit for HBV and HCV using rapid testing. HBV-positive women were linked to care and initiated on tenofovir disoproxil fumarate (TDF) prophylaxis. The proportion of newborns receiving timely HepB-BD vaccination (within 24 h of birth) was measured pre- and post-intervention. Statistical analysis was performed using paired t -tests and Chi-squared. Results: A total of 2844 pregnant women were screened for HBV and HCV. The pooled prevalence of HBV infection among the study population was found to be 1.86% (95% CI: 1.35%–2.37%), six times higher than HCV (0.3%). A Chi-squared test for homogeneity was conducted to determine if the proportion of HBV-reactive individuals varied significantly across the five facilities. The test revealed a statistically significant difference in HBV prevalence across facilities (χ 2 = 11.49, df = 4, p = 0.021). Most women (53.4%) booked ANC in the second trimester. Prior to intervention, the probability of administering the HepB vaccine to any child, whether newborn or older infants, on any day of the week, including weekends, was 40% because vaccination was not conducted daily in any of the pilot facilities. Post-intervention, this rose to 100% as all pilot facilities adopted daily vaccination practice. In comparison with the previous study of 5.8%, HepB-BD timely uptake within 24 h, post-intervention, was 100% across all pilot facilities. Conclusion: Project StopHepB interventions significantly improved early identification, linkage to care, and timely HepB-BD vaccination, effectively closing gaps in HBV prevention of perinatal transmission. These findings support the scale-up of similar interventions to advance HBV elimination goals across other facilities in the state, in Nigeria, and to prevent new HBV infections in the future.

  • Open Access

    Physical distancing for reducing and mitigating COVID-19 transmission: A rapid review

    by Ekpereonne B. Esu, Ehimario U. Igumbor, Anthony T. Okoro, Patience O. Idiege, Kelechi Meremikwu, Angela E. Oyo-Ita, Kathleen A. Dunn, Hannah H. Hurwitz, Martin M. Meremikwu

    Background: Physical distancing is an infection prevention and control (IPC) intervention and public health and social measure (PHSM) aimed at reducing respiratory infections. However, the optimal distance for preventing severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) transmission remains uncertain. Aim: This study aimed to determine whether a distance of 1 m is optimal for reducing SARS-CoV-2 transmission. Setting: Community and healthcare settings. Methods: The Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, PubMed and Embase were searched for studies conducted in community, healthcare and other defined settings between 01 January 2020 and 07 September 2022. The quality of the evidence was assessed with the ROBINS-I tool. This study is registered on PROSPERO (CRD42022355706). Results: One retrospective cohort study enrolled 242 school districts in Massachusetts, United States, which included 537 336 students and 99 390 staff attending in-person instruction between September 2020 and January 2021. No significant differences in SARS-CoV-2 cases were observed among both groups for students (adjusted incidence rate ratio [aIRR]: 0.904; 95% confidence interval [CI]: 0.616–1.325) and staff (aIRR: 1.015; 95% CI: 0.754–1.366). Conclusion: In this sole study, SARS-CoV-2 cases were similar regardless of physical distance (1 metre vs 2 metres), although they studied a limited number of events. Physical distancing was part of a broader set of mitigation measures employed in the study setting; including consistent mask use. Contribution: The effectiveness of physical distancing against SARS-CoV-2 infection is significantly influenced by mask use, thus its impact on physical distancing effectiveness cannot be separated. Further studies are needed to increase the certainty of the evidence.

  • Open Access

    Combatting anthrax outbreaks across Nigeria’s national land borders: need to optimize surveillance with epidemiological surveys

    by Hammed O. Mogaji, Babatunde Adewale, Stella I. Smith, Ehimario U. Igumbor, Chidumebi J. Idemili, Andrew W. Taylor-Robinson

    Background: Anthrax is a non-contagious zoonotic disease caused by the Gram-positive, spore-forming bacterium Bacillus anthracis. Infection is common in livestock and wild animals such as cattle, goats, sheep, camels, and antelopes. In humans, anthrax may occur after contact with contaminated carcasses or animal products like milk and meat. The best method to prevent anthrax in people is to ensure livestock are vaccinated, which significantly limits the risk of zoonotic spread to humans. However, the rate of vaccination of domesticated animals kept by nomadic pastoralists in West Africa is low. These groups regularly cross over national boundaries with their grazing herds. Nigeria is a country that historically has done comparatively well to contain this public health threat. However, in 2023 several outbreaks of human disease appear linked to the consumption of anthrax-contaminated animal products brought into Nigeria by pastoralists from neighboring countries. Clinical manifestations include skin sores or ulcers, nausea, vomiting, and fever. This article aims to raise awareness of recent outbreaks of anthrax in West Africa and to call for a renewed focus on measures to combat this neglected public health concern to the region. Main body: The imperative to pinpoint pivotal issues relating to the ongoing emergence of anthrax cases in Nigeria cannot be overstated. By delving into the prevalence of anthrax in both livestock and human populations residing along Nigeria’s borders, unraveling the genetic diversity and potential sources of B. anthracis strains, and identifying the primary animal host(s) responsible for transmission, we stand to enhance our understanding of this critical issue. Furthermore, investigating the multifaceted factors contributing to anthrax transmission, assessing community knowledge and practices, mapping common migratory routes of pastoralists, and formulating targeted intervention strategies tailored to the challenges of border communities, are each crucial steps towards effective control and prevention. Conclusion: Closing these knowledge gaps on anthrax is not only essential for safeguarding both animal and human health but also for fostering sustainable and resilient communities. Addressing research questions on these interdisciplinary concerns will undoubtedly pave the way for informed decision-making, proactive measures, and a more secure future for Nigeria and its border regions. Graphical


  • Open Access

    Places Nigerians visited during COVID-19 government stay-home policy: evidence from secondary analysis of data collected during the lockdown

    by David Idowu Olatunji, Babasola Oluwatomi Okusanya, Bassey Ebenso, Sophia Ifeoma Usuwa, David Akeju, Samuel Adejoh, Chinwe Lucia Ochu, Michael Amedu Onoja, James Olatunde Okediran, Gloria Ogochukwu Nwiyi, et al.

    Introduction: Compliance with the Government’s lockdown policy is required to curtail community transmission of Covid-19 infection. The objective of this research was to identify places Nigerians visited during the lockdown to help prepare for a response towards future infectious diseases of public health importance similar to Covid-19. Methods: This was a secondary analysis of unconventional data collected using Google Forms and online social media platforms during the COVID-19 lockdown between April and June 2020 in Nigeria. Two datasets from: i) partnership for evidence-based response to COVID-19 (PERC) wave-1 and ii) College of Medicine, University of Lagos perception of and compliance with physical distancing survey (PCSH) were used. Data on places that people visited during the lockdown were extracted and compared with the sociodemographic characteristics of the respondents. Descriptive statistics were calculated for all independent variables and focused on frequencies and percentages. Chi-squared test was used to determine the significance between sociodemographic variables and places visited during the lockdown. Statistical significance was determined by P0.05. All statistical analyses were carried out using SPSS version 22. Results: There were 1304 and 879 participants in the PERC wave-1 and PCSH datasets, respectively. The mean age of PERC wave-1 and PCSH survey respondents was 31.8 [standard deviation (SD)=8.5] and 33.1 (SD=8.3) years, respectively. In the PCSH survey, 55.9% and 44.1% of respondents lived in locations with partial and complete covid-19 lockdowns, respectively. Irrespective of the type of lockdown, the most common place visited during the lockdown was the market (shopping); reported by 73% of respondents in states with partial lockdown and by 68% of respondents in states with the complete lockdown. Visits to families and friends happened more in states with complete (16.1%) than in states with partial (8.4%) lockdowns.Conclusions: Markets (shopping) were the main places visited during the lockdown compared to visiting friends/family, places of worship, gyms, and workplaces. It is important in the future for the Government to plan how citizens can safely access markets and get other household items during lockdowns for better adherence to stay-at-home directives for future infectious disease epidemics.


  • Open Access

    Epidemiology and psychosocial assessment of COVID-19 among workersof the Nigeria Centre for Disease Control infected with COVID-19

    by Fatima Saleh, David Idowu Olatunji, Ehichioya Ofeimun, Evaezi Okpokoro, Emily Crawford, Mahmood Dalhat, Ehimario Igumbor, Sunday Eziechina, Stella Inweregbu, Chinwe Lucia Ochu, et al.

    Background. COVID-19 is a global health crisis. By 2021, Nigeria had 230,000 cases. As the national public health institute, NCDC leads the COVID-19 response. Due to constant contact with infected patients, agency employees are at high-risk. Here, we describe the transmission and psychosocial effects of COVID-19 among infected NCDC workers as a learning curve for minimizing occupational transmission among frontline public health workers in future outbreaks.Methods. We approved and enrolled all NCDC COVID-19-infected personnel from November to December 2020. We collected data using SurveyMonkey. STATA 14 analyzed the data.Results. 172 of 300 afflicted NCDC staff participated in this study. One-third were between 30 and 39; most were male (104, 60.5%). Most participants worked in the lab (30%) or surveillance (24%). Only 19% (33/172) of participants confirmed pandemic deployment. Most reported interaction with a confirmed case (112/65.1%). Most people (78, 45.3%) felt unhappy when diagnosed. Anger, worry, and low motivation also ranked high (19). The majority reported adequate financial, moral, or psychosocial assistance (26, 70.6%).Conclusions. NCDC staff had a high SARS-CoV-2 infection rate and emotional damage. We urge stricter infection control methods when sending staff for outbreaks response to prevent additional transmission, as well as ongoing psychosocial and economic assistance for afflicted workers.


  • “Straddling Adolescence” - Perspective on the State of Research on Infectious Diseases in Nigeria.

    by Igumbor Ehi

    On the heels of the convergence of world infectious diseases experts in Kuala Lumpur, Malaysia for the congress of the International Society for Infectious Diseases (ISID) from 17-20 November 2022, the global challenge of infectious diseases was recognised, without equivocation, as requiring local solutions. From nascent pandemics such as COVID-19, to more established pandemics like HIV/AIDS, and epidemics of mpox, Lassa fever, influenza, Yellow Fever, Ebola and cholera, the call for better local science to inform local action was emphasized. This is more so pressing in resource-limited settings such as we find across many of our communities in Nigeria. Keywords: Infectious diseases, COVID-19, HIV, Lassa fever, Nigeria, Pandemics Citation: Igumbor Ehi ( 2023), “Straddling Adolescence” - Perspective on the State of Research on Infectious Diseases in Nigeria.. Journal of the Nigerian Infectious Diseases Society, 2(1): 4-5 Received: ; Accepted: ; Published: 31/10/2023 Copyright: Nigerian Infectious Diseases Society. All rights reserved.. All rights reserved. *Correspondence: Igumbor Ehi, ehi.igumbor@gmail.com

  • Open Access

    Erythromycin, Retapamulin, Pyridoxine, Folic acid and Ivermectin dose dependently inhibit cytopathic effect, Papain-like Protease and M PRO of SARS-CoV-2

    by Shaibu Oricha Bello, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, et al.

    We previously showed that Erythromycin, Retapamulin, Pyridoxine, Folic acid and Ivermectin inhibit SARS-COV-2 induced cytopathic effect (CPE) in Vero cells. In this study and using validated quantitative neutral red assay, we show that the inhibition of CPE is concentration dependent with Inhibitory Concentration-50(IC 50 ) of 3.27 μM, 4.23 μM, 9.29 μM, 3.19 μM and 84.31 μM respectively. Furthermore, Erythromycin, Retapamulin, Pyridoxine, Folic acid and Ivermectin dose dependently inhibit SARS-CoV-2 Papain-like Protease with IC 50 of 0.94 μM, 0.88 μM, 1.14 μM, 1.07 μM, 1.51 μM respectively and the main protease(M PRO ) with IC 50 of 1.35 μM, 1.25 μM, 7.36 μM, 1.15 μM and 2.44 μM respectively. The IC 50 for all the drugs, except ivermectin, are at the clinically achievable plasma concentration in human, which supports a possible role for the drugs in the management of COVID-19. The lack of inhibition of CPE by Ivermectin at clinical concentrations could be part of the explanation for its lack of effectiveness in clinical trials.


  • Open Access

    Innovative, rapid, high-throughput method for drug repurposing in a pandemic – a case study of SARS-CoV-2 and COVID-19

    by Shaibu Oricha Bello, Abdulmajeed Yunusa, Adamu Ahmed Adamu, Mustapha Umar Imam, Muhammad Bashir Bello, Abdulmalik Shuaibu, Ehimario Uche Igumbor, Zaiyad Garba Habib, Mustapha Ayodele Popoola, Chinwe Lucia Ochu, et al.

    Several efforts to repurpose drugs for COVID-19 treatment have largely either failed to identify a suitable agent or agents identified did not translate to clinical use; either because of demonstrated lack of clinical efficacy in trials, inappropriate dose requirements and probably use of inappropriate pre-clinical laboratory surrogates of effectiveness. In this study, we used an innovative algorithm, that incorporates dissemination and implementation considerations, to identify potential drugs for COVID-19 using iterative computational and wet laboratory methods that highlight inhibition of viral induced cytopathic effect (CPE) as a laboratory surrogate of effectiveness. Erythromycin, pyridoxine, folic acid and retapamulin were found to inhibit SARS-CoV-2 induced CPE in Vero cells at concentrations that are clinically achievable. Additional studies may be required to further characterize the inhibitions of CPE and the possible mechanisms. Funding TETFund Covid-19 Special Intervention Research grant(grant number TETFund/DR&D/CE/ SI/COVID-19/UDUS/VOL 1)


  • Open Access

    Seroprevalence of SARS-CoV-2 in four states of Nigeria in October 2020: A population-based household survey

    by Rosemary A. Audu, Kristen A. Stafford, Laura Steinhardt, Zaidat A. Musa, Nnaemeka Iriemenam, Elsie Ilori, Natalia Blanco, Andrew Mitchell, Yohhei Hamada, Mirna Moloney, et al.

    The observed epidemiology of SARS-CoV-2 in sub-Saharan Africa has varied greatly from that in Europe and the United States, with much lower reported incidence. Population-based studies are needed to estimate true cumulative incidence of SARS-CoV-2 to inform public health interventions. This study estimated SARS-CoV-2 seroprevalence in four selected states in Nigeria in October 2020. We implemented a two-stage cluster sample household survey in four Nigerian states (Enugu, Gombe, Lagos, and Nasarawa) to estimate age-stratified prevalence of SARS-CoV-2 antibodies. All individuals in sampled households were eligible for interview, blood draw, and nasal/oropharyngeal swab collection. We additionally tested participants for current/recent malaria infection. Seroprevalence estimates were calculated accounting for the complex survey design. Across all four states, 10,629 (96·5%) of 11,015 interviewed individuals provided blood samples. The seroprevalence of SARS-CoV-2 antibodies was 25·2% (95% CI 21·8–28·6) in Enugu State, 9·3% (95% CI 7·0–11·5) in Gombe State, 23·3% (95% CI 20·5–26·4) in Lagos State, and 18·0% (95% CI 14·4–21·6) in Nasarawa State. Prevalence of current/recent malaria infection ranged from 2·8% in Lagos to 45·8% in Gombe and was not significantly related to SARS-CoV-2 seroprevalence. The prevalence of active SARS-CoV-2 infection in the four states during the survey period was 0·2% (95% CI 0·1–0·4). Approximately eight months after the first reported COVID-19 case in Nigeria, seroprevalence indicated infection levels 194 times higher than the 24,198 officially reported COVID-19 cases across the four states; however, most of the population remained susceptible to COVID-19 in October 2020.


  • Open Access

    Is There Risk Compensation among HIV Infected Youth and Adults 15 Years and Older on Antiretroviral Treatment in South Africa? Findings from the 2017 National HIV Prevalence, Incidence, Behaviour and Communication Survey

    by Nompumelelo Zungu, Musawenkosi Mabaso, Shandir Ramlagan, Leickness Simbayi, Sizulu Moyo, Olive Shisana, Pelagia Murangandi, Ehimario Igumbor, Salome Sigida, Sean Jooste, et al.

    In this paper, risk compensation among individuals on antiretroviral therapy (ART), using the 2017 South African national survey on HIV, is explored. A multi-stage stratified cluster random sampling approach was used to realize 11,130 participants 15 years and older. Logistic regression analysis assessed the association between multiple sexual partners, condom use at last sexual encounter, consistency of condom usage and potential explanatory variables using HIV status and ART exposure as a mediator variable. HIV positive participants who were aware and on ART were less likely to have multiple sexual partners, and less likely not to use a condom at last sex compared to HIV positive participants who were aware but not on ART. The odds of reporting multiple sexual partners were significantly lower among older age groups, females, non-Black Africans, and rural settings, and higher among those with tertiary level education, and risky alcohol users. The odds of no condom use at last sexual encounter were more likely among older age groups, females, other race groups, and less likely among those with secondary level education. The odds of inconsistent condom use were more likely among older age groups, females, and other race groups, and less likely among those with tertiary level education, high risk and hazardous alcohol users. Risk compensation is not apparent among HIV infected adults who are on ART. Risk groups that should receive tailored interventions to reduced risky sexual behaviours were identified.